Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
King Abdullah International Medical Research Center (KAIMRC) held the 10th Annual Forum for Medical Research under the slogan “Improving healthcare through high standard clinical trials.” The forum celebrated the first phase I clinical trial to be held in the kingdom, testing a vaccine against MERS-CoV.
Researchers, regulators, and experts from the medical industry gathered for the tenth year to share knowledge and exchange experiences on advancing the medical field through translational research.
Forum participants made suggestions about how Saudi Arabia can reach its ambitious 2030 targets to increase clinical trials from six trials per 1,000 doctors to 100 trials, and capture 1% of the global $1.5 billion annual pharmaceutical investments in clinical trials.
The forum celebrated the success of a three-year effort that resulted in KAIMRC kicking off the first phase I clinical trial in Saudi Arabia, testing a potential vaccine against MERS-CoV.